Literature DB >> 22509895

Comparative analysis of the chemical profiles of 3,4-methylenedioxymethamphetamine based on comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GC × GC-TOFMS).

Marion Schäffer1, Thomas Gröger, Michael Pütz, Susanne Dieckmann, Ralf Zimmermann.   

Abstract

The chemical profiling of illicit drugs is an important analytical tool to support the work of investigating and law enforcement authorities. In our work, comprehensive two-dimensional gas chromatography-time-of-flight mass spectrometry (GC × GC-TOFMS) combined with nontargeted, pixel-based data analysis was adapted for the chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA). The validity and benefit of this approach was evaluated by analyzing a well-investigated set of MDMA samples. Samples were prepared according to a harmonized extraction protocol to ensure the comparability of the chemical signatures. The nontargeted approach comprises preprocessing followed by analysis of variances as a fast filter algorithm for selection of a variable subset followed by partial least squares discriminant analysis for reduction to promising marker compounds for discrimination of the samples according to their chemical profile. Forty-seven potential marker compounds were determined, covering most of the target impurities known from the harmonized one-dimensional profiling as well as other compounds not previously elucidated.
© 2012 American Academy of Forensic Sciences.

Entities:  

Year:  2012        PMID: 22509895     DOI: 10.1111/j.1556-4029.2012.02137.x

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  1 in total

1.  Unsupervised classification of petroleum Certified Reference Materials and other fuels by chemometric analysis of gas chromatography-mass spectrometry data.

Authors:  Werickson Fortunato de Carvalho Rocha; Michele M Schantz; David A Sheen; Pamela M Chu; Katrice A Lippa
Journal:  Fuel (Lond)       Date:  2017-02-23       Impact factor: 6.609

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.